Insiders · AVXL

Terrie Kellmeyer

President and CEO, Director at Anavex Life Sciences Corp. (AVXL) since May 2026

Terrie Kellmeyer has filed 2 insider reports with the SEC since May 2026, as president and CEO and director at Anavex Life Sciences Corp. (AVXL). The latest filing, on November 7, 2026, reports grant or award at Anavex Life Sciences Corp. (AVXL).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Terrie Kellmeyer is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Anavex Life Sciences Corp. logo
AVXL
Anavex Life Sciences Corp.
President and CEO, Directorsince May 2026$0.6675Nov 7, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Terrie Kellmeyer with

Other insiders at the same companies

Questions about Terrie Kellmeyer

What is Terrie Kellmeyer's role at Anavex Life Sciences Corp.?
Terrie Kellmeyer reports to the SEC as president and CEO and director at Anavex Life Sciences Corp. (AVXL), according to the latest filing on November 7, 2026.
Has Terrie Kellmeyer bought or sold stock recently?
No open-market purchases or sales by Terrie Kellmeyer are on file. The filings report grant or award.
How do I get alerts when Terrie Kellmeyer files?
Follow Terrie Kellmeyer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Terrie Kellmeyer filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Terrie Kellmeyer (SEC CIK 0002135020). Totals count each trade once, skipping amendments whose original is on file, from May 14, 2026 on. View on SEC EDGAR · Get this as JSON